VKH
STAB

Virtu KCG Holdings’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Virtu KCG Holdings’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$154K Buy
52,091
+38,233
+276% +$125K ﹤0.01% 2277
2017
Q1 		$22K Sell
13,858
-17,286
-56% -$28.7K ﹤0.01% 2966
2016
Q4 		$44K Buy
31,144
+14,267
+85% +$22.5K ﹤0.01% 3114
2016
Q3 		$28K Buy
+16,877
New +$37.1K ﹤0.01% 2888
2016
Q2 		– Sell
-14,973
Closed -$38K – 3443
2016
Q1 		$38K Sell
14,973
-6,029
-29% -$20.3K ﹤0.01% 2514
2015
Q4 		$73K Buy
21,002
+9,980
+91% +$40.2K ﹤0.01% 3074
2015
Q3 		$48K Sell
11,022
-11,618
-51% -$47.3K ﹤0.01% 3004
2015
Q2 		$98K Buy
22,640
+5,720
+34% +$17.2K ﹤0.01% 2918
2015
Q1 		$60K Buy
16,920
+12,254
+263% +$50.3K ﹤0.01% 2793
2014
Q4 		$27K Buy
4,666
+4,150
+804% +$32.5K ﹤0.01% 3565
2014
Q3 		$5K Sell
516
-13
-2% -$119 ﹤0.01% 3518
2014
Q2 		$5K Sell
529
-1,526
-74% -$17.8K ﹤0.01% 3566
2014
Q1 		$28K Sell
2,055
-864
-30% -$14.1K ﹤0.01% 3401
2013
Q4 		$68K Buy
2,919
+2,167
+288% +$58.9K ﹤0.01% 3538
2013
Q3 		$23K Buy
+752
New +$24.9K ﹤0.01% 3605

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu KCG Holdings's STAB Position: Q2 2017 in Review

Virtu KCG Holdings increased its Statera Biopharma, Inc. Common Stock (STAB) stake by 276% in Q2 2017, buying an estimated $125K and bringing the position to 52,091 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Virtu KCG Holdings first reported a position in STAB in Q3 2013 and has held it in 15 quarters since. 20 funds tracked by Wall St. Rank hold STAB as of Q2 2017.

  • Virtu KCG Holdings held 52,091 shares of Statera Biopharma, Inc. Common Stock worth $154K as of Q2 2017.
  • Virtu KCG Holdings bought 38,233 Statera Biopharma, Inc. Common Stock shares in Q2 2017, an estimated $125K.
  • Statera Biopharma, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2277 holding.
  • Virtu KCG Holdings first reported a position in Statera Biopharma, Inc. Common Stock in Q3 2013 and has held it in 15 quarters since.
  • 20 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.